Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
0.0290
+0.0020 (7.41%)
At close: Sep 11, 2026
SGXC:9G2 Revenue
In the fiscal year ending June 30, 2026, Singapore Institute of Advanced Medicine Holdings had annual revenue of 15.72M SGD with 0.05% growth. Singapore Institute of Advanced Medicine Holdings had revenue of 3.65M in the quarter ending June 30, 2026, a decrease of -1.98%.
Revenue
15.72M
Revenue Growth
+0.05%
P/S Ratio
3.18
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 15.72M | 8.38K | 0.05% |
| Jun 30, 2025 | 15.71M | -936.78K | -5.63% |
| Jun 30, 2024 | 16.65M | 412.41K | 2.54% |
| Jun 30, 2023 | 16.23M | 2.43M | 17.56% |
| Jun 30, 2022 | 13.81M | 891.35K | 6.90% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UG Healthcare Corporation | 150.82M |
| Lincotrade & Associates Holdings | 129.50M |
| ISOTeam | 105.75M |
| Wong Fong Industries | 79.06M |
| Attika Group | 37.42M |
| Atlantic Navigation Holdings (Singapore) | 28.20M |
| KOP Limited | 19.82M |
| HC Surgical Specialists | 19.73M |